Transformation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma (NCT05970666) | The First Affiliated Hospital of Xiamen University | 2023-11-15 |
Track Transformation automatically
Every clearance here is in the API, with alerts when new ones post.